Vietnam Ventricular Assist Devices (VAD) Market Size, Share, Trends and Forecast by Product, Flow Type, Product Type, Application, End User, and Region, 2026-2034

Vietnam Ventricular Assist Devices (VAD) Market Summary:

The Vietnam ventricular assist devices (VAD) market size was valued at USD 11.34 Million in 2025 and is projected to reach USD 22.03 Million by 2034, growing at a compound annual growth rate of 7.66% from 2026-2034.

The market is gaining steady momentum as the country strengthens its advanced cardiac care capabilities and expands access to modern heart failure therapies. Increasing awareness of mechanical circulatory support options, evolving surgical expertise, and growing healthcare investments are contributing to broader adoption. Improvements in device technology, coupled with rising demand for long-term ventricular support among patients with end-stage heart failure, are reinforcing the market’s trajectory and positioning Vietnam as an emerging player in advanced cardiac treatment across Southeast Asia, thereby strengthening Vietnam ventricular assist devices (VAD) market share.

Key Takeaways and Insights:

• By Product: Left ventricular assist device (LVAD) dominates the market with a share of 56.8% in 2025, driven by the critical need for left ventricular support in advanced heart failure management.
   
• By Flow Type: Non-pulsatile or Continuous flow devices lead the market with a share of 79.4% in 2025, owing to their superior hemodynamic performance, compact design, and improved patient survival outcomes.
   
• By Product Type: Implantable ventricular assist devices hold the largest share at 72.1% in 2025, supported by growing preference for long-term circulatory support and enhanced device miniaturization.
   
• By Application: Bridge-to-transplant (BTT) therapy represents the largest segment with 41.6% share in 2025, reflecting the growing transplant waitlist and need for interim mechanical support.
   
• By End User: Hospitals account for the largest share at 83.7% in 2025, driven by the concentration of advanced cardiac surgical capabilities and specialized intensive care facilities.
   
• By Region: Southern Vietnam leads the market with a 46.9% share in 2025, attributed to the presence of leading tertiary hospitals and higher healthcare spending in Ho Chi Minh City.
   
• Key Players: The Vietnam VAD market features a moderately competitive landscape, with international medical device manufacturers leveraging distribution networks, clinical partnerships, and technology transfer programs to strengthen their presence across the country.

To get more information on this market Request Sample

The market for ventricular assist devices in the Vietnamese market is expected to grow as the healthcare infrastructure is modernized and the quality of healthcare for the population improves. The increasing heart failure cases due to lifestyle and dietary changes and the increasing average age of the population are also expected to contribute positively to the growth of the market. The government's initiatives in the healthcare sector, such as increasing insurance cover and modernizing hospitals and providing incentives for the development of medical technology with other countries, are also expected to positively impact the growth of the market. The increasing number of collaborations between hospitals in the country and other countries for the development of the skills required for the implantation of ventricular assist devices are also expected to positively impact the growth of the market. The increasing number of people in the higher income group with increasing disposable income is also expected to positively impact the growth of the market. In the coming years, household spending is expected to increase by 6.0 percent in real terms and reach VNĐ3.6 quadrillion ($138.5 billion), an increase compared to the pre-Covid period of VNĐ2.77 quadrillion in 2019.

Vietnam Ventricular Assist Devices (VAD) Market Trends:

Advancing Cardiac Surgical Expertise and Transplant Capabilities

The landscape of cardiological care in Vietnam is evolving, with hospitals building advanced surgical capabilities. For example, Viet Duc Friendship Hospital in Hanoi performed 15 organ transplants from four deceased donors over a period of six days, with four of the recipients being heart transplant patients, one being a combined liver and kidney transplant patient, three being liver transplant patients, and seven being kidney transplant patients. The growing transplant program is raising demand for mechanical circulatory support for patients awaiting transplant, supporting Vietnam ventricular assist devices market growth.

Growing Integration of Minimally Invasive Device Technologies

Healthcare institutions in Vietnam are showing greater interest in minimally invasive heart procedures to achieve better results and minimize complications associated with heart surgeries. Modern ventricular assist devices that make use of fully magnetically levitated pumps, which are small in size, are being increasingly used in tertiary care centers. This technology has helped patients recover quickly, minimize complications, and enjoy a better quality of life while suffering from chronic heart failure. In 2026, Physicians at Ho Chi Minh City University Medical Center have successfully performed a complicated heart procedure involving aortic valve replacement along with coronary bypass grafting, employing a total 3D endoscopic method, which is a first of its kind in Vietnam. This has been announced on January 12, which reflects the significance of this procedure as a landmark in minimally invasive heart procedures in the nation.

Expansion of Private Hospital Networks and Cardiac Specialization

The rapid growth in the number of private healthcare facilities in Vietnam is providing opportunities for the increased use of advanced cardiac devices. Presently, the number of private hospitals in Vietnam is increasing and is likely to increase in the future. Presently, the number of beds in private hospitals in Vietnam makes up only 8% of the total number of beds in Vietnam. However, the government aims to increase this number to 15% by the year 2030 and to 25% by the year 2050. There is an emergence of specialty centers for cardiovascular care that are providing opportunities for the increased use of mechanical circulatory support devices.

Market Outlook 2026-2034:

The Vietnam ventricular assist devices market is positioned for sustained expansion through the forecast period, supported by improving healthcare infrastructure, growing clinical expertise in advanced cardiac interventions, and expanding access to modern heart failure treatment modalities. The market generated a revenue of USD 11.34 Million in 2025 and is projected to reach a revenue of USD 22.03 Million by 2034, growing at a compound annual growth rate of 7.66% from 2026-2034. Strengthening government policies, deeper international medical partnerships, and increasing public awareness of heart failure management are expected to drive higher adoption rates and foster a more competitive, mature, and innovative VAD landscape across Vietnam.

Vietnam Ventricular Assist Devices (VAD) Market Report Segmentation:

Product Insights:

• Left Ventricular Assist Device (LVAD)
• Right Ventricular Assist Device (RVAD)
• Biventricular Assist Device (BiVAD)
• Others

Left ventricular assist device (LVAD) segment leads the market with a revenue share of 56.8% of the total Vietnam ventricular assist devices market in 2025.

Left ventricular assist devices are the most widely utilized form of mechanical circulatory support in Vietnam’s cardiac care ecosystem. The left ventricle serves as the heart’s primary pumping chamber, making it the most clinically relevant target for device-assisted support when heart function deteriorates. Hospitals across Vietnam are increasingly integrating LVADs into their advanced heart failure treatment protocols, driven by improvements in device safety, durability, and patient management systems.

The adoption of LVADs is further supported by the expanding transplant program in Vietnam, where these devices serve as essential bridging solutions for patients awaiting heart transplantation. Continuous advancements in pump technology, including compact, fully magnetically levitated designs, are enhancing clinical outcomes and reducing complication rates. Growing physician training and knowledge exchange with international cardiac centers are reinforcing LVAD adoption across the country.

Flow Type Insights:

• Pulsatile Flow
• Non-Pulsatile or Continuous Flow

Non-pulsatile or continuous flow dominates the market with a share of approximately 79.4% in the Vietnam ventricular assist devices market in 2025.

Non-pulsatile or continuous flow ventricular assist devices have become the preferred technology in Vietnam’s cardiac care facilities owing to their smaller size, improved energy efficiency, and reduced mechanical complexity compared to older pulsatile alternatives. These devices offer enhanced reliability and longer operational life, which are critical considerations in resource-constrained healthcare environments where device replacement and maintenance logistics present challenges.

The dominance of continuous flow technology is reinforced by the broader global shift toward this platform, which has demonstrated superior patient survival rates and lower complication profiles in clinical practice. Vietnamese cardiac centers, benefiting from international training partnerships and technology transfer, are increasingly standardizing continuous flow VADs as the foundation of their mechanical circulatory support programs, further consolidating this segment’s market position.

Product Type Insights:

• Implantable Ventricular Assist Devices
• Non-implantable Ventricular Assist Devices

Implantable ventricular assist devices account for the largest segment with 72.1% of the Vietnam ventricular assist devices market in 2025.

Implantable ventricular assist devices hold the dominant position in the Vietnam market as they provide sustained, long-term hemodynamic support for patients with severe heart failure. These devices are surgically placed within the body, enabling patients to resume relatively normal daily activities while receiving continuous cardiac assistance. The preference for implantable systems reflects growing confidence among Vietnamese surgeons in performing complex device implantation procedures.

Advancements in implantable device design, including miniaturized pumps, reduced driveline profiles, and wireless monitoring capabilities, are making these systems more suitable for a broader range of patient populations. Hospitals in major urban centers are leading adoption, supported by investment in specialized cardiac surgical infrastructure. As clinical expertise deepens and healthcare access expands, implantable VADs are expected to maintain their dominant share in the Vietnamese market.

Application Insights:

Access the comprehensive market breakdown Request Sample

• Bridge-to-Transplant (BTT) Therapy
• Destination Therapy
• Bridge to Recovery and Bridge to Candidacy

Bridge-to-transplant therapy holds the largest share at approximately 41.6% of the Vietnam ventricular assist devices market in 2025.

Bridge-to-transplant therapy represents the primary clinical application for ventricular assist devices in Vietnam, reflecting the critical role of mechanical circulatory support in sustaining patients awaiting heart transplantation. As Vietnam’s organ transplant program continues to grow, the gap between transplant demand and donor organ availability necessitates reliable interim support solutions that can maintain patient stability and quality of life during extended waiting periods.

The expansion of transplant-capable hospitals across Vietnam is driving the utilization of bridge-to-transplant VADs. With the country performing over one thousand organ transplants annually and advancing complex multi-organ procedures, the need for effective bridging devices is intensifying. Hospitals are increasingly incorporating VADs into their cardiac care pathways to ensure that patients remain viable transplant candidates throughout the waiting process.

End User Insights:

• Ambulatory Surgery Centers
• Hospitals
• Others

Hospitals represent the leading category with a share of 83.7% of the Vietnam ventricular assist devices market in 2025.

Hospitals serve as the primary setting for ventricular assist device implantation and management in Vietnam, owing to the complex surgical requirements, intensive postoperative monitoring, and specialized multidisciplinary care teams necessary for successful VAD therapy. Major public and private hospitals in urban centers have invested in building dedicated cardiac surgery units, intensive care capabilities, and post-implant follow-up programs to support the growing demand for mechanical circulatory support.

The concentration of advanced medical equipment, trained cardiac specialists, and critical care infrastructure within hospital settings makes them the natural center for VAD procedures. Government initiatives to modernize hospital infrastructure and expand specialized cardiac services are further reinforcing this segment’s dominance. As healthcare reform continues and more hospitals achieve cardiac surgery certification, the hospital channel is expected to sustain its commanding position in the Vietnam VAD market.

Regional Insights:

• Northern Vietnam
• Central Vietnam
• Southern Vietnam

Southern Vietnam dominates the Vietnam ventricular assist devices market with a 46.9% share in 2025.

Southern Vietnam, anchored by Ho Chi Minh City, represents the largest regional market for ventricular assist devices, benefiting from the highest concentration of advanced tertiary hospitals, private healthcare facilities, and cardiac specialty centers in the country. The region’s higher per capita healthcare spending, larger insured population, and greater availability of specialized medical professionals create a favorable environment for the adoption of advanced cardiac devices.

Ho Chi Minh City hosts several internationally accredited hospitals that have pioneered complex cardiac procedures, including organ transplantation and advanced interventional cardiology. The region also benefits from stronger foreign investment in healthcare infrastructure and closer ties with international medical technology providers, facilitating earlier access to next-generation VAD systems. As the southern healthcare ecosystem continues to mature, the region is expected to retain its leadership position in the Vietnam VAD market.

Market Dynamics:

Growth Drivers:

Why is the Vietnam Ventricular Assist Devices (VAD) Market Growing?

Rising Prevalence of Heart Failure and Cardiovascular Diseases

Vietnam is experiencing a growing burden of cardiovascular diseases, driven by shifting lifestyle patterns, urbanization, and the rising prevalence of chronic risk factors such as hypertension, diabetes, and obesity. Cardiovascular conditions remain the leading cause of non-communicable disease-related deaths in the country, placing immense pressure on the healthcare system. Cardiovascular disease results in approximately 200,000 fatalities annually in Vietnam, amidst a concerningly young age of onset for the illness. As heart failure cases increase, particularly among the aging population, the demand for advanced mechanical circulatory support solutions continues to grow. Patients with end-stage heart failure who do not respond to conventional pharmacological therapies require device-assisted interventions to sustain cardiac function and improve survival. This expanding patient pool is creating a sustained and growing need for ventricular assist devices across both public and private healthcare facilities in Vietnam.

Expanding Healthcare Infrastructure and Hospital Modernization

Vietnam’s healthcare sector is undergoing significant transformation, with substantial investments directed toward upgrading hospital infrastructure, expanding specialty care capabilities, and improving access to advanced medical technologies. The government has prioritized healthcare development through national reform programs that encourage public-private partnerships, attract foreign investment, and modernize clinical service delivery. Private hospital expansion, particularly in cardiology and cardiac surgery, is creating new facilities equipped to perform complex device implantation procedures. Additionally, increased healthcare spending and broader insurance coverage are enabling more patients to access advanced therapies, including ventricular assist devices. These structural improvements are building the foundation for greater VAD adoption and positioning Vietnam to address the growing demand for advanced heart failure management across the nation. In 2026, Cho Ray Hospital has launched an interventional cardiology system worth VND 500 billion, representing a significant advancement in enhancing its ability to diagnose and manage intricate cardiovascular diseases in southern Vietnam.

Limited Donor Organ Availability and Growing Transplant Waitlists

Despite significant progress in organ transplantation, Vietnam continues to face a critical shortage of donor organs relative to demand. In 2024, almost 4,000 individuals were on the national organ transplant waiting list, stated Associate Professor Dong Van He, Director of the National Coordinating Center for Human Organ Transplantation. The gap between patients awaiting heart transplants and available donor hearts necessitates reliable mechanical circulatory support solutions that can sustain patients through extended waiting periods. Ventricular assist devices serve as essential bridge-to-transplant tools, maintaining hemodynamic stability and preserving organ function until a suitable donor becomes available. As the transplant waitlist grows and more hospitals develop transplantation capabilities, the clinical dependency on VADs as interim and, increasingly, long-term support devices is intensifying. This fundamental supply-demand imbalance in donor organs is a structural driver that ensures sustained demand for mechanical circulatory support in Vietnam.

Market Restraints:

What Challenges the Vietnam Ventricular Assist Devices (VAD) Market is Facing?

High Cost of Device Implantation and Maintenance

The substantial financial burden associated with ventricular assist device procurement, surgical implantation, and ongoing maintenance remains a significant barrier to broader adoption in Vietnam. These costs often exceed the financial capacity of many patients and strain public hospital budgets, limiting the number of procedures performed annually. Inadequate reimbursement frameworks and limited insurance coverage for advanced cardiac devices further restrict patient access and constrain overall market penetration.

Limited Specialized Cardiac Infrastructure in Rural Areas

Advanced cardiac care capabilities, including VAD implantation expertise, specialized intensive care units, and multidisciplinary heart failure teams, remain concentrated in major urban centers such as Ho Chi Minh City and Hanoi. Rural and semi-urban regions face significant gaps in specialized healthcare infrastructure, preventing equitable access to mechanical circulatory support therapies. This geographic disparity limits the addressable patient population and slows the decentralization of advanced cardiac care across the country.

Low Awareness of Mechanical Circulatory Support Options

Public and clinical awareness of ventricular assist devices as a viable treatment option for advanced heart failure remains limited in Vietnam. Many patients and healthcare providers in secondary care settings are unfamiliar with VAD therapy, its clinical benefits, and patient selection criteria. This knowledge gap delays referrals to specialized centers and reduces the number of patients considered for device implantation, hindering the growth of the overall market.

Competitive Landscape:

The Vietnam ventricular assist devices market exhibits a moderately concentrated competitive structure, shaped by the specialized nature of cardiac assist technologies and the high barriers to entry associated with regulatory approvals, clinical validation, and distribution network development. Market participants compete on the basis of device reliability, clinical performance, miniaturization, patient comfort, and post-implantation support services. Strategic partnerships with leading hospitals and academic medical centers play a critical role in building clinical credibility and facilitating product adoption. Technology transfer agreements, physician training programs, and after-sales service networks are key differentiating factors among market participants. The competitive environment is further influenced by ongoing innovations in pump technology, driveline design, and remote patient monitoring capabilities. As the Vietnamese healthcare system continues to modernize and expand its cardiac care capacity, the competitive landscape is expected to evolve with greater emphasis on comprehensive support ecosystems.

Vietnam Ventricular Assist Devices (VAD) Market Report Coverage: